AVENCELL

Live / Applied — Third extension granted (statement of use) (as of 08 Jan 2026)

What this means for you

Not registered yet, but its 30 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97773407
Mark type
Stylized text
Filed
30 Jan 2023
Published for opposition
21 May 2024
Attorney of record
Emilia F. Cannella

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of cancer and autoimmune diseases; pharmaceutical preparations, namely, T-cell based therapeutics to treat cancer and autoimmune disease
  • Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics

Owner

Prosecution history

  • 09 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 08 Jan 2026 — SOU EXTENSION 3 GRANTED
  • 08 Jan 2026 — SOU EXTENSION 3 FILED
  • 08 Jan 2026 — SOU TEAS EXTENSION RECEIVED
  • 25 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 24 Jun 2025 — SOU EXTENSION 2 GRANTED
  • 24 Jun 2025 — SOU EXTENSION 2 FILED
  • 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 14 Jan 2025 — SOU EXTENSION 1 GRANTED
  • 14 Jan 2025 — SOU EXTENSION 1 FILED
  • 14 Jan 2025 — SOU TEAS EXTENSION RECEIVED
  • 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 May 2024 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy